MT-ATP6 variant as a cause of adult-onset hereditary spastic paraparesis: A case report and literature review
Open Access
- 12 November 2025
- journal article
- Published by SAGE Publications in Journal of Neuromuscular Diseases
- Vol. 13 (4) , 832-839
Abstract
Background: Hereditary spastic paraplegia (HSP) is a heterogenous group of rare genetic disorders characterized by progressive corticospinal and dorsal spinal cord axonal degeneration manifesting as muscle weakness and spasticity of the lower extremities. Over 98% of solved HSP cases are caused by pathogenic variants in the nuclear DNA. Case: We report a family carrying the m.9035T > C [p.(Leu170Pro)] pathogenic variant in the mitochondrial MT - ATP6 gene in the setting of maternally inherited, late-onset HSP. The proband (age 67 years) presented with classical, late-onset, pure HSP. Her affected daughter (age 39 years) developed late-onset, complex HSP, with asymmetrical axonal sensorimotor polyneuropathy. Her second daughter (age 46 years) carried the same pathogenic variant with high heteroplasmy but was clinically unaffected at last assessment, suggesting age-dependent or incomplete penetrance. Summary of literature: The substitution of a leucine for a proline affects a highly conserved transmembrane helix of the subunit “a” at a key functional domain in the mitochondrial ATP synthase complex. The m.9035T > C variant has been reported in several families presenting with common phenotypic presentations of ATP6-related disorders such as maternally inherited Leigh syndrome (MILS) and the syndrome of neuropathy, ataxia, and retinitis pigmentosa (NARP). HSP is a rare presentation in ATP6-related disorders; mitochondrial ATP6-induced HSP has previously been published in only one family carrying a homoplasmic m.9176T > C [p.(Leu217Pro)] variant. Conclusion: This report highlights the role of MT-ATP6 pathogenic variants in complex and pure HSP and raises the relevance of genetic testing of MT-ATP6 in undiagnosed cases of sporadic or maternally inherited HSP.Keywords
Funding Information
- Genome Canada
- Genome Alberta
- Ontario Research Foundation
- Génome Québec
- Ontario Genomics Institute (OGI-147)
- Genome British Columbia
- Children's Hospital of Eastern Ontario Foundation
- Canadian Institutes of Health Research
This publication has 28 references indexed in Scilit:
- Bi‐Allelic COQ4 Variants Cause Adult‐Onset Ataxia‐Spasticity Spectrum DiseaseMovement Disorders, 2022
- Mutations in MT-ATP6 are a frequent cause of adult-onset spinocerebellar ataxiaJournal of Neurology, 2021
- Challenges and Controversies in the Genetic Diagnosis of Hereditary Spastic ParaplegiaCurrent Neurology and Neuroscience Reports, 2021
- Specifications of the ACMG/AMP standards and guidelines for mitochondrial DNA variant interpretationHuman Mutation, 2020
- Deciphering exome sequencing data: Bringing mitochondrial DNA variants to lightHuman Mutation, 2019
- Pathogenic variants in MT‐ATP6: A United Kingdom–based mitochondrial disease cohort studyAnnals of Neurology, 2019
- MT-ATP6mitochondrial disease variants: Phenotypic and biochemical features analysis in 218 published cases and cohort of 14 new casesHuman Mutation, 2019
- Mitochondrial DNA polymorphisms/haplogroups in hereditary spastic paraplegiaJournal of Neurology, 2011
- Identification of ataxia‐associated mtDNA mutations (m.4052T>C and m.9035T>C) and evaluation of their pathogenicity in transmitochondrial cybridsMuscle & Nerve, 2009
- Novel heteroplasmic mtDNA mutation in a family with heterogeneous clinical presentationsAnnals of Neurology, 2001